Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients.

Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients.

<h4>Background</h4>High-frequency image-guided radiotherapy (hfIGRT) is ubiquitous but its benefits are unproven. We examined the cost effectiveness of hfIGRT in stage III non-small-cell lung cancer (NSCLC).<h4>Methods</h4>We selected stage III NSCLC patients ≥66 years old wh...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Samuel P Heilbroner, Eric P Xanthopoulos, Donna Buono, Daniel Carrier, Ben Y Durkee, Michael Corradetti, Tony J C Wang, Alfred I Neugut, Dawn L Hershman, Simon K Cheng
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/a119368c9c4c4b05909411626be4498b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a119368c9c4c4b05909411626be4498b

Ejemplares similares